Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Gastroenterology ; 166(1): 88-102, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37704112

RESUMO

BACKGROUND & AIMS: There is a need to develop safe and effective pharmacologic options for the treatment of celiac disease (CeD); however, consensus on the appropriate design and configuration of randomized controlled trials (RCTs) in this population is lacking. METHODS: A 2-round modified Research and Development/University of California Los Angeles Appropriateness Method study was conducted. Eighteen gastroenterologists (adult and pediatric) and gastrointestinal pathologists voted on statements pertaining to the configuration of CeD RCTs, inclusion and exclusion criteria, gluten challenge, and trial outcomes. Two RCT designs were considered, representing the following distinct clinical scenarios for which pharmacotherapy may be used: trials incorporating a gluten challenge to simulate exposure; and trials evaluating reversal of histologic changes, despite attempted adherence to a gluten-free diet. Each statement was rated as appropriate, uncertain, or inappropriate, using a 9-point Likert scale. RESULTS: For trials evaluating prevention of relapse after gluten challenge, participants adherent to a gluten-free diet for 12 months or more with normal or near-normal-sized villi should be enrolled. Gluten challenge should be FODMAPS (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) free, and efficacy evaluated using histology with a secondary patient-reported outcome measure. For trials evaluating reversal of villus atrophy, the panel voted it appropriate to enroll participants with a baseline villus height to crypt depth ratio ≤2 and measure efficacy using a primary histologic end point. Guidance for measuring histologic, endoscopic, and patient-reported outcomes in adult and pediatric patients with CeD are provided, along with recommendations regarding the merits and limitations of different end points. CONCLUSIONS: We developed standardized recommendations for clinical trial design, eligibility criteria, outcome measures, gluten challenge, and disease evaluations for RCTs in patients with CeD.


Assuntos
Doença Celíaca , Adulto , Humanos , Criança , Doença Celíaca/patologia , Recidiva Local de Neoplasia , Ensaios Clínicos Controlados Aleatórios como Assunto , Glutens/efeitos adversos , Dieta Livre de Glúten
2.
Dig Dis Sci ; 68(5): 1718-1727, 2023 05.
Artigo em Inglês | MEDLINE | ID: mdl-36436154

RESUMO

BACKGROUND: Despite regular need for colonoscopy in patients with Crohn's disease (CD), the efficacy and tolerability of bowel preparation (BP) agents is rarely assessed in this population. Assessing BP quality with existing scales may be challenging in CD due to presence of inflammation, bowel resection, and strictures. AIMS: To provide recommendations for assessing BP quality in clinical trials for CD using a modified Research and Development/University of California, Los Angeles appropriateness process. METHODS: Based on systematic reviews and a literature search, 110 statements relating to BP quality assessment in CD were developed. A panel of 15 gastroenterologists rated the statements as appropriate, uncertain, or inappropriate using a 9-point Likert scale. RESULTS: Panelists considered it appropriate that central readers, either alone or with local assessment, score BP quality in clinical trials. Central readers should be trained on scoring BP quality and local endoscopists on performing high-quality video recording. Both endoscope insertion and withdrawal phases should be reviewed to score BP quality in each colonic segment and segments should align with endoscopic disease activity indices. The Harefield Cleansing Scale and the Boston Bowel Preparation Scale were considered appropriate. The final score should be calculated as the average of all visualized segments. Both total and worst segment scores should also be assessed. CONCLUSIONS: We developed a framework for assessing BP quality in patients with CD based on expert feedback. This framework could support the development or refinement of BP quality scales and the integration of BP quality assessment in future CD studies.


Assuntos
Colo , Colonoscopia , Doença de Crohn , Humanos , Consenso , Constrição Patológica , Doença de Crohn/diagnóstico , Doença de Crohn/tratamento farmacológico
3.
J Neurosci ; 28(43): 11003-14, 2008 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-18945908

RESUMO

Paranodal axoglial junctions are essential for the segregation of myelinated axons into distinct domains and efficient conduction of action potentials. Here, we show that netrin-1 and deleted in colorectal cancer (DCC) are enriched at the paranode in CNS myelin. We then address whether netrin-1 signaling influences paranodal adhesion between oligodendrocytes and axons. In the absence of netrin-1 or DCC function, oligodendroglial paranodes initially develop and mature normally but later become disorganized. Lack of DCC or netrin-1 resulted in detachment of paranodal loops from the axonal surface and the disappearance of transverse bands. Furthermore, the domain organization of myelin is compromised in the absence of netrin-1 signaling: K+ channels inappropriately invade the paranodal region, and the normally restricted paranodal distribution of Caspr expands longitudinally along the axon. Our findings identify an essential role for netrin-1 and DCC regulating the maintenance of axoglial junctions.


Assuntos
Axônios/fisiologia , Junções Comunicantes/fisiologia , Fatores de Crescimento Neural/fisiologia , Oligodendroglia/fisiologia , Receptores de Superfície Celular/fisiologia , Proteínas Supressoras de Tumor/fisiologia , Animais , Animais Recém-Nascidos , Axônios/ultraestrutura , Moléculas de Adesão Celular/metabolismo , Moléculas de Adesão Celular Neuronais/metabolismo , Cerebelo/citologia , Cerebelo/crescimento & desenvolvimento , Cerebelo/metabolismo , Receptor DCC , Junções Comunicantes/ultraestrutura , Regulação da Expressão Gênica/genética , Masculino , Camundongos , Camundongos Knockout , Microscopia Eletrônica de Transmissão/métodos , Proteína Básica da Mielina/metabolismo , Fatores de Crescimento Neural/deficiência , Fatores de Crescimento Neural/metabolismo , Netrina-1 , Técnicas de Cultura de Órgãos/métodos , Ratos , Ratos Sprague-Dawley , Receptores de Superfície Celular/deficiência , Retina/metabolismo , Retina/transplante , Transplante de Células-Tronco/métodos , Células-Tronco/fisiologia , Fatores de Tempo , Proteínas Supressoras de Tumor/deficiência
4.
Curr Opin Neurobiol ; 16(5): 529-34, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16935486

RESUMO

Netrins are a small family of secreted proteins that are best known for their role as secreted long-range chemotropic guidance cues. Extracellular gradients of netrin protein, established by diffusion, are thought to direct cell and axon migration during neural development. In addition to this long-range role, recent findings provide increasing support for short-range functions, in which secreted netrin protein remains closely associated with its cellular source. Emerging evidence for short-range actions of netrins suggests that they contribute to tissue morphogenesis by regulating cell-cell and cell-matrix adhesion.


Assuntos
Axônios/fisiologia , Adesão Celular/fisiologia , Morfogênese/fisiologia , Fatores de Crescimento Neural/metabolismo , Sistema Nervoso/crescimento & desenvolvimento , Animais , Difusão , Humanos , Sistema Nervoso/embriologia
5.
Prog Neurobiol ; 79(2): 73-94, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16824663

RESUMO

A disintegrin and metalloprotease (ADAM) transmembrane proteins have metalloprotease, integrin-binding, intracellular signaling and cell adhesion activities. In contrast to other metalloproteases, ADAMs are particularly important for cleavage-dependent activation of proteins such as Notch, amyloid precursor protein (APP) and transforming growth factor alpha (TGFalpha), and can bind integrins. Not surprisingly, ADAMs have been shown or suggested to play important roles in the development of the nervous system, where they regulate proliferation, migration, differentiation and survival of various cells, as well as axonal growth and myelination. On the eleventh anniversary of the naming of this family of proteins, the relatively unknown ADAMs are emerging as potential therapeutic targets for neural repair. For example, over-expression of ADAM10, one of the alpha-secretases for APP, can prevent amyloid formation and hippocampal defects in an Alzheimer mouse model. Another example of this potential neural repair role is the finding that ADAM21 is uniquely associated with neurogenesis and growing axons of the adult brain. This comprehensive review will discuss the growing literature about the roles of ADAMs in the developing and adult nervous system, and their potential roles in neurological disorders. Most excitingly, the expanding understanding of their normal roles suggests that they can be manipulated to promote neural repair in the degenerating and injured adult nervous system.


Assuntos
Proteínas ADAM/metabolismo , Regeneração Nervosa/fisiologia , Sistema Nervoso/crescimento & desenvolvimento , Plasticidade Neuronal/fisiologia , Proteínas ADAM/química , Proteínas ADAM/genética , Animais , Diferenciação Celular/fisiologia , Movimento Celular/fisiologia , Proliferação de Células , Humanos , Modelos Moleculares , Bainha de Mielina/metabolismo , Neovascularização Fisiológica , Sistema Nervoso/metabolismo , Neurônios/citologia , Neurônios/fisiologia
6.
Brain Res ; 1130(1): 54-66, 2007 Jan 26.
Artigo em Inglês | MEDLINE | ID: mdl-17161391

RESUMO

Loss and damage to blood vessels are thought to contribute to secondary tissue loss after spinal cord injury. Integrins might be therapeutic targets to protect the vasculature and/or promote angiogenesis, as their activation can promote tubule formation and survival of endothelial cells in vitro. Here, we show that immunostaining with an antibody against the alpha1beta1 integrin heterodimer is present only in blood vessels from postnatal day 1 (P1) through adulthood in Sprague-Dawley rats. After a spinal cord contusion at T9 in adults, the area of alpha1beta1 integrin positive blood vessels increases within 11 mm from the injury site at 3 days post-injury and remains prominent within the injured core only at 7 days. Staining for the alpha6beta1 integrin heterodimer increases in blood vessels between P10 and adulthood and is present in preganglionic neurons of the intermediolateral cell column (IML) at all ages. The alpha6beta1 integrin is also expressed by motor neurons postnatally, and oligodendrocyte precursors (OPCs), as previously reported. After the contusion, the area of alpha6beta1-stained blood vessels is increased at 3 days and most prominently, 1 mm from the injury site, followed by a significant reduction at 7 days, when alpha6beta1 integrin staining is most prominent around the injured core. Staining is also present in a subset of microglia and/or macrophages. These results raise the possibility that alpha1beta1 and alpha6beta1 integrins in blood vessels might be targeted to reduce blood vessel loss and promote angiogenesis, which may promote tissue sparing after spinal cord injury.


Assuntos
Vasos Sanguíneos/metabolismo , Integrina alfa1beta1/metabolismo , Integrina alfa6beta1/metabolismo , Neovascularização Fisiológica/fisiologia , Traumatismos da Medula Espinal/metabolismo , Fatores Etários , Animais , Feminino , Neurônios Motores/metabolismo , Oligodendroglia/citologia , Oligodendroglia/metabolismo , Ratos , Ratos Sprague-Dawley , Medula Espinal/irrigação sanguínea , Medula Espinal/citologia , Medula Espinal/metabolismo , Células-Tronco/citologia , Células-Tronco/metabolismo , Vértebras Torácicas , Fatores de Tempo , Cicatrização/fisiologia
8.
J Comp Neurol ; 486(4): 318-30, 2005 Jun 13.
Artigo em Inglês | MEDLINE | ID: mdl-15846787

RESUMO

Terminally differentiated neurons derived from a human teratocarcinoma cell line (NT2N or hNT neurons) are promising as a cell source for transplantation, as they have been shown to be safe for transplantation in humans. We have shown previously that hNT neurons can express a catecholaminergic phenotype in a rat Parkinson model. In this study, we investigated the long-term survival and ability of hNT neurons to express tyrosine hydroxylase and reconstruct the dopamine-denervated nigrostriatal pathway. Hemiparkinsonian rats received grafts of 400,000 viable hNT neurons into each of the denervated striatum and substantia nigra. Robust hNT grafts were detected up to 24 weeks posttransplantation, although few cells expressed tyrosine hydroxylase. Many hNT fibers were often associated with ipsilateral and contralateral white matter tracts--corpus callosum, rostral migratory stream, optic tract, and external capsule. Fewer fibers were associated with the superior cerebellar peduncle, medial lemniscus, and nigrostriatal pathway. Axons also projected into the frontal cortex and extended parallel to the surface of the brain in the superficial cortical layers. These pathways were seen in all grafted animals, suggesting that specific guidance cues exist in the adult brain governing hNT fiber outgrowth. Injured adult axons and transplanted embryonic neuronal axons rarely extend for such distances in the adult nervous system. We propose that elucidating the factors promoting and guiding hNT axonal outgrowth could provide important clues to enhancing regeneration and target reinnervation in the adult brain, two factors of critical importance for cell restoration strategies aimed at brain repair.


Assuntos
Corpo Estriado/fisiologia , Fibras Nervosas/fisiologia , Neurônios/transplante , Substância Negra/fisiologia , Adrenérgicos/toxicidade , Anfetamina/farmacologia , Animais , Axônios/fisiologia , Comportamento Animal/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Transplante de Células/métodos , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/cirurgia , Ciclosporina/farmacologia , Feminino , Lateralidade Funcional , Sobrevivência de Enxerto/efeitos dos fármacos , Sobrevivência de Enxerto/fisiologia , Humanos , Imunossupressores/farmacologia , Atividade Motora/efeitos dos fármacos , Fibras Nervosas/efeitos dos fármacos , Vias Neurais/efeitos dos fármacos , Vias Neurais/fisiologia , Vias Neurais/cirurgia , Neuritos/fisiologia , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Oxidopamina/toxicidade , Fosfopiruvato Hidratase/metabolismo , Distribuição Aleatória , Ratos , Ratos Wistar , Teste de Desempenho do Rota-Rod/métodos , Substância Negra/efeitos dos fármacos , Substância Negra/cirurgia , Teratocarcinoma , Transplante Heterólogo , Tirosina 3-Mono-Oxigenase/metabolismo
9.
J Comp Neurol ; 490(2): 163-79, 2005 Sep 19.
Artigo em Inglês | MEDLINE | ID: mdl-16052496

RESUMO

We have reported that alpha6beta1 integrin regulates the directed migration of neuroblasts from the adult rodent subventricular zone (SVZ) through the rostral migratory stream (RMS). ADAM (a disintegrin and metalloprotease) proteins bind integrins. Here, we show that ADAM21, but not ADAM2, -3, -9, -10, -12, -15, or -17, is expressed in adult rats and mice by ependyma and SVZ cells with long basal processes, and in radial glia at early postnatal times. ADAM21-positive processes projected into the RMS, contacted blood vessels, and were present within the RMS intermingled with neuroblasts up to where neuroblasts start their radial migration and differentiation in the olfactory bulb. Tissue inhibitors of metalloproteases (TIMPs) 1, 2, and 3 are present in the ependymal layer but not in the SVZ and RMS. Thus, ADAM21 could regulate neurogenesis and guide neuroblast migration through cleavage-dependent activation of proteins and integrin binding. ADAM21 is also present in growing axonal tracts during postnatal development and in growing primary olfactory axons in adults. In the olfactory nerve layer, ADAM21 often, but not always, colocalizes with OMP, a marker of mature olfactory neurons, but is not colocalized with the immature marker betaIII-tubulin. This suggests that ADAM21 is involved in the final axonal outgrowth phase and/or synapse formation. TIMP3 is present in periglomerular neurons, where it could restrict ADAM21-mediated axonal growth to the glomeruli. ADAM21's unique disintegrin and metalloprotease sequences and its restricted expression suggest that it might be a good target for influencing neurogenesis and neuronal plasticity.


Assuntos
Axônios/metabolismo , Sistema Nervoso Central/crescimento & desenvolvimento , Regulação da Expressão Gênica no Desenvolvimento/fisiologia , Proteínas de Membrana/fisiologia , Metaloendopeptidases/fisiologia , Neurônios/fisiologia , Proteínas ADAM , Animais , Animais Recém-Nascidos , Western Blotting/métodos , Bromodesoxiuridina/metabolismo , Diferenciação Celular , Proliferação de Células , Sistema Nervoso Central/citologia , Sistema Nervoso Central/metabolismo , Proteína Glial Fibrilar Ácida/metabolismo , Imuno-Histoquímica/métodos , Integrina alfa6beta1/metabolismo , Masculino , Proteínas de Membrana/genética , Metaloendopeptidases/genética , Camundongos , Camundongos Endogâmicos C57BL , Proteínas do Tecido Nervoso/metabolismo , Proteína de Marcador Olfatório , Organogênese , Fosfopiruvato Hidratase/metabolismo , Recombinases Rec A/metabolismo , Tubulina (Proteína)/metabolismo , Vimentina/metabolismo
10.
J Neurotrauma ; 22(4): 415-28, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15853460

RESUMO

A therapeutic strategy for acute spinal cord injury would be to reduce the progressive degeneration and disconnection of axons from their targets. Here, we describe a model to evaluate degeneration of the ascending sensory projections to the nuclei in the medulla following graded spinal cord contusions in adult female Sprague-Dawley rats. Cholera toxin B (CTB) labeling from the sciatic nerve of naive rats revealed effective labeling of the terminal fibers in the gracile nucleus at 3 days post-injection and a subpopulation of rapidly transporting fibers after 1 day. Seven days after contusions using the Infinite Horizon impactor the area of CTB-labeled terminal fibers had a negative correlation with increasing impact force. Moderate spinal contusions of around 150 kilodyne (kdyn or 0.15 x 10(-3) newton) caused a reduction to 40% in the fiber area which will enable the identification of protective as well as detrimental drugs and post-injury mechanisms. A preconditioning injury of the sciatic nerve reportedly can enhance growth of sensory axons but did not affect the terminal fiber area in the gracile nucleus. Estrogen and progesterone are protective in various systems and could therefore influence experimental outcomes when using females. However, the phase of the estrus cycle at the time of contusion or during the post-injury time did not affect the outcome of the contusion, indicating that female rats may be used without consideration of the estrus cycle. This model can readily be used to evaluate pharmacological agents for protection of sensory axons and pathophysiological mechanisms of their degeneration.


Assuntos
Modelos Animais de Doenças , Ciclo Estral/fisiologia , Neurônios Aferentes/patologia , Neuropatia Ciática/fisiopatologia , Traumatismos da Medula Espinal/fisiopatologia , Degeneração Walleriana/fisiopatologia , Vias Aferentes/lesões , Vias Aferentes/patologia , Vias Aferentes/fisiopatologia , Animais , Transporte Axonal/fisiologia , Axônios/patologia , Fenômenos Biomecânicos , Toxina da Cólera , Estrogênios/metabolismo , Feminino , Fármacos Neuroprotetores/metabolismo , Progesterona/metabolismo , Ratos , Ratos Sprague-Dawley , Fatores de Tempo , Degeneração Walleriana/patologia
11.
Inflamm Bowel Dis ; 20(10): 1850-61, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25029615

RESUMO

BACKGROUND: Crohn's disease (CD) is a chronic idiopathic inflammatory disorder of the gastrointestinal tract. Recently, mucosal healing has been proposed as a goal of therapy because clinical symptoms are subjective. Evaluative indices that measure endoscopic disease activity are required to define mucosal healing for clinical trials. The primary objective of this systematic review was to assess the existing evaluative indices that measure disease activity in CD and evaluate their role as outcome measures in clinical trials. METHODS: A systematic literature review was performed using MEDLINE (Ovid), EMBASE (Ovid), PubMed, the Cochrane Library (CENTRAL), and DDW abstracts to identify randomized controlled trials and controlled clinical trials that used a relevant evaluative index from inception to February 2013. The data obtained from these trials were reviewed and summarized. RESULTS: The initial literature searches identified 2300 citations. After duplicates were removed, 1454 studies remained. After application of the apriori inclusion and exclusion criteria, 109 articles were included and 3 were identified with handsearches. In total, 9 evaluative indices for CD were identified and reviewed. The Crohn's Disease Endoscopic Index of Severity (CDEIS) and the Simple Endoscopic Score in Crohn's Disease (SES-CD) are indices with the most extensively described operating properties. CONCLUSIONS: Both the endoscopic evaluative instrument selected and the definition chosen for mucosal healing affect the validity of assessing endoscopic disease activity during a clinical trial for CD. Currently, the CDEIS and SES-CD have the most data regarding operating properties; however, further validation is required.


Assuntos
Doença de Crohn/patologia , Doença de Crohn/terapia , Endoscopia/métodos , Mucosa/fisiopatologia , Projetos de Pesquisa , Índice de Gravidade de Doença , Cicatrização , Pesquisa Biomédica , Ensaios Clínicos como Assunto , Guias como Assunto , Humanos
12.
Development ; 136(3): 415-26, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19141671

RESUMO

The molecular mechanisms underlying the elaboration of branched processes during the later stages of oligodendrocyte maturation are not well understood. Here we describe a novel role for the chemotropic guidance cue netrin 1 and its receptor deleted in colorectal carcinoma (Dcc) in the remodeling of oligodendrocyte processes. Postmigratory, premyelinating oligodendrocytes express Dcc but not netrin 1, whereas mature myelinating oligodendrocytes express both. We demonstrate that netrin 1 promotes process extension by premyelinating oligodendrocytes in vitro and in vivo. Addition of netrin 1 to mature oligodendrocytes in vitro evoked a Dcc-dependent increase in process branching. Furthermore, expression of netrin 1 and Dcc by mature oligodendrocytes was required for the elaboration of myelin-like membrane sheets. Maturation of oligodendrocyte processes requires intracellular signaling mechanisms involving Fyn, focal adhesion kinase (FAK), neuronal Wiscott-Aldrich syndrome protein (N-WASP) and RhoA; however, the extracellular cues upstream of these proteins in oligodendrocytes are poorly defined. We identify a requirement for Src family kinase activity downstream of netrin-1-dependent process extension and branching. Using oligodendrocytes derived from Fyn knockout mice, we demonstrate that Fyn is essential for netrin-1-induced increases in process branching. Netrin 1 binding to Dcc on mature oligodendrocytes recruits Fyn to a complex with the Dcc intracellular domain that includes FAK and N-WASP, resulting in the inhibition of RhoA and inducing process remodeling. These findings support a novel role for netrin 1 in promoting oligodendrocyte process branching and myelin-like membrane sheet formation. These essential steps in oligodendroglial maturation facilitate the detection of target axons, a key step towards myelination.


Assuntos
Extensões da Superfície Celular/fisiologia , Fatores de Crescimento Neural/fisiologia , Oligodendroglia/fisiologia , Proteínas Proto-Oncogênicas c-fyn/fisiologia , Receptores de Superfície Celular/fisiologia , Proteínas Supressoras de Tumor/fisiologia , Proteína rhoA de Ligação ao GTP/fisiologia , Animais , Forma Celular/fisiologia , Células Cultivadas , Receptor DCC , Quinase 1 de Adesão Focal/genética , Quinase 1 de Adesão Focal/fisiologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Knockout , Bainha de Mielina/fisiologia , Fatores de Crescimento Neural/genética , Netrina-1 , Oligodendroglia/citologia , Ligação Proteica , Proteínas Proto-Oncogênicas c-fyn/genética , Ratos , Ratos Sprague-Dawley , Receptores de Superfície Celular/genética , Transdução de Sinais/fisiologia , Proteínas Supressoras de Tumor/genética , Proteína Neuronal da Síndrome de Wiskott-Aldrich/genética , Proteína Neuronal da Síndrome de Wiskott-Aldrich/fisiologia , Proteína cdc42 de Ligação ao GTP/fisiologia , Proteína rhoA de Ligação ao GTP/genética
13.
Exp Neurol ; 205(1): 82-91, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17316612

RESUMO

By reducing the progressive degeneration and disconnection of axons following spinal cord injury the functional outcome should improve. After direct transection of dorsal column sensory axons, neurotrophin-3 (NT-3) treatment can reduce degeneration and promote regeneration of the proximal stumps. Here, we tested in adult rats whether NT-3 infusion at the site of a moderate T9 spinal cord contusion would rescue sensory connections to the gracile nucleus in the medulla. Sensory projections were anterogradely traced bilaterally with injections of cholera toxin B (CTB) into the sciatic nerve 3 days before analysis. Seven days after the contusion plus intrathecal (subarachnoid) vehicle infusion as a control, the CTB-positive innervation of the gracile nucleus was reduced to approximately 25% of sham-operated rats. Intrathecal infusion of 10 microg/day of NT-3 did not affect this reduced innervation. To ensure good tissue penetration and high concentrations of NT-3 early after the injury, other rats received intraparenchymal infusions of vehicle or NT-3 near the injury site starting 2 days before until 7 days after the injury. This NT-3 treatment also did not affect the reduced innervation. This suggests that local NT-3 treatments cannot protect sensory axons from secondary degeneration after a contusive spinal cord injury. These results are likely because TrkC is not present in axons of the dorsal columns or gracile nucleus, or in other dorsal column cell types, even after the contusion. Together with published results, our data suggest that NT-3 is a peripherally--but not centrally--derived neurotrophic factor for sensory neurons.


Assuntos
Contusões/metabolismo , Neurônios Aferentes/metabolismo , Neurotrofina 3/farmacologia , Receptor trkC/deficiência , Traumatismos da Medula Espinal/metabolismo , Medula Espinal/efeitos dos fármacos , Medula Espinal/metabolismo , Vias Aferentes/metabolismo , Vias Aferentes/fisiopatologia , Animais , Axônios/efeitos dos fármacos , Axônios/metabolismo , Cateteres de Demora , Toxina da Cólera/administração & dosagem , Contusões/complicações , Contusões/fisiopatologia , Esquema de Medicação , Feminino , Bulbo/fisiopatologia , Degeneração Neural/etiologia , Degeneração Neural/prevenção & controle , Neurônios Aferentes/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Ratos , Ratos Sprague-Dawley , Receptor trkC/metabolismo , Nervo Isquiático/fisiopatologia , Medula Espinal/patologia , Medula Espinal/fisiopatologia , Traumatismos da Medula Espinal/complicações , Traumatismos da Medula Espinal/fisiopatologia
14.
Neurobiol Dis ; 18(3): 523-7, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15755679

RESUMO

Testing the effects of drugs that stimulate endogenous neurogenesis in different species is important for the development of neural repair strategies in humans. We have previously shown in adult rats that a 14-day intracerebroventricular infusion of the D3 preferential agonist 7-hydroxydipropyl-amino-tetraline (7-OH-DPAT) increases BrdU labeling of neural precursors in the subventricular zone of the anterior lateral ventricle (SVZ). Here, we show that such a treatment failed to affect neurogenesis in C57Bl/6 and FVB mice, even at a high dose or when infused into the neostriatum. We confirmed that such a treatment was effective in adult rats. Moreover, D3 receptor inhibition or genetic knockout failed to affect the neurogenesis in mice. These results raise the possibilities that neurogenesis is not regulated by D3 receptors in all species and, therefore, that D3 agonists like pramipexole may not be useful to harness endogenous neurogenesis in cell replacement strategies for Parkinson's disease.


Assuntos
Ventrículos Laterais/citologia , Ventrículos Laterais/fisiologia , Neurônios/citologia , Neurônios/fisiologia , Receptores de Dopamina D2/fisiologia , Animais , Antagonistas dos Receptores de Dopamina D2 , Feminino , Ventrículos Laterais/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Neurônios/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Receptores de Dopamina D2/agonistas , Receptores de Dopamina D3 , Tetra-Hidronaftalenos/farmacologia
15.
Eur J Neurosci ; 20(2): 575-9, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15233767

RESUMO

An understanding of the regulators of neurogenesis in the normal and diseased brain is necessary in order to recruit endogenously produced neural precursors for cell replacement in neurodegenerative disorders such as Parkinson's disease. The location of dopaminergic projections from the midbrain to the neostriatum and nucleus accumbens overlaps with the most active region of neurogenesis in the adult brain, the subventricular zone of the anterior lateral ventricle. This suggests that dopamine may contribute to regulation of the subventricular niche of adult neurogenesis. Here, we show in adult mice that destruction of the dopaminergic neurons in the substantia nigra and ventral tegmental area in a 6-hydroxydopamine model of Parkinson's disease reduced the number of proliferating neural precursors in the subventricular zone of the anterior lateral ventricle by approximately 40%. The effect on neural precursor proliferation correlated with the extent of dopaminergic denervation in the neighboring neostriatum. This identifies dopamine as one of the few known endogenous regulators of adult neurogenesis with implications for the potential use of endogenous neural precursors in cell replacement strategies for Parkinson's disease.


Assuntos
Divisão Celular/fisiologia , Corpo Estriado/metabolismo , Dopamina/metabolismo , Ventrículos Laterais/citologia , Neurônios/fisiologia , Animais , Bromodesoxiuridina/farmacocinética , Contagem de Células/métodos , Corpo Estriado/efeitos dos fármacos , Modelos Animais de Doenças , Imuno-Histoquímica/métodos , Ventrículos Laterais/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Neurônios/efeitos dos fármacos , Oxidopamina/toxicidade , Doença de Parkinson/fisiopatologia , Substância Negra/efeitos dos fármacos , Tirosina 3-Mono-Oxigenase/metabolismo , Área Tegmentar Ventral/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA